INTERNATIONAL PATENT: WUXI BIOLOGICS (SHANGHAI) CO., LTD., 上海药明生物技术有限公司, WUXI BIOLOGICS IRELAND LIMITED, 药明生物技术爱尔兰有限公司 FILES APPLICATION FOR "METHOD FOR ELIMINATING O-XYLOSYLATION MODIFICATION OF RECOMBINANT PROTEIN"

Posted On: 2025-09-28

GENEVA, Sept. 28 -- WUXI BIOLOGICS (SHANGHAI) CO., LTD. (No. 299 Fute Zhong Road, Pudong New AreaShanghai 200131), 上海药明生物技术有限公司 (中国上海市浦东新区富特中路299号), WUXI BIOLOGICS IRELAND LIMITED (Mullagharlin, Dundalk, Co LouthA91X56F), 药明生物技术爱尔兰有限公司 (爱尔兰劳斯郡邓达克穆拉加林) filed a patent application (PCT/CN2025/083406) for "METHOD FOR ELIMINATING O-XYLOSYLATION MODIFICATION OF RECOMBINANT PROTEIN" on Mar ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: WUXI BIOLOGICS (SHANGHAI) CO., LTD., 上海药明生物技术有限公司, WUXI BIOLOGICS IRELAND LIMITED, 药明生物技术爱尔兰有限公司 FILES APPLICATION FOR "METHOD FOR ELIMINATING O-XYLOSYLATION MODIFICATION OF RECOMBINANT PROTEIN"